🔎 Trials Near Me

Home › Muscle Spasticity › NCT05926596

Leg Stretching Using an Exoskeleton on Demand for People With Spasticity

Recruiting

Leg Stretching Using a Controllable Wearable Exoskeleton on Demand for People With Spasticity

Who can join

Ages 18 and older · All sexes

Full eligibility criteria
Inclusion Criteria:

* Veteran individuals with spasticity due to spinal cord injury (SCI) at least 6 months post SCI
* Capable of providing informed consent and reporting age, gender, and neurological condition
* Neurologically stable (\>6 months post-SCI) and can wear the device and the sensors, provide written informed consent, and follow instruction

Exclusion Criteria:

* Participants should not experience another neurological disorder except their primary diagnosed neurological condition (spinal cord injury)
* Participants should not be pregnant
* Participants should weigh less than 300 lbs
* Participants should not have experienced signs of hip/knee pain during the past 2-3 weeks that limits mobility (i.e., reaching, walking, lifting, etc.)
* Participants should be recovered from any previous surgical interventions, joint injuries, muscle strain, or extreme muscle soreness following surgery
* Participants should not take medications known to affect bone metabolism, muscle strength or cardiovascular performance or have any ailments causing high fever, high blood pressure, or high heart rate

About the study

The purpose of this research study is to develop a protocol using a fully wearable, portable lower-limb exoskeleton for improving leg and walking function in people with movement disorders. The study investigates the effects of wearing the device during a set of experiments including leg stretching, treadmill walking and overground walking in muscle activity, joint motion, and gait performance. The goal is to develop an effective lower-limb strategy to restore lost leg function (e.g., range of motion) and gait ability, and improve quality of life in people with movement deficits following a neurological disorder.

What is being tested

Sponsor: VA Office of Research and Development · Participants: 10 · Started: Feb 9, 2026

Contact the study team

Official record on ClinicalTrials.gov — NCT05926596

Locations in the U.S.

New YorkSyracuse VA Medical Center, Syracuse, NY, Syracuse

Conditions

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.